Navigation Links
Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer

iming, design, enrollment and cost of clinical trials; unexpected delays in clinical trials and preparation of materials for submission to the FDA as part of our NDA filing; our ability to establish successful partnerships and collaborations with third parties; the regulatory approval process in the United States and other countries; and our future capital requirements. For further information about these risks and other factors that may affect the actual results achieved by Pharmacyclics, please see the company's reports as filed with the U.S. Securities and Exchange Commission from time to time, including but not limited to its annual report on Form 10-K for the period ended June 30, 2006 and its subsequently filed quarterly reports on Form 10-Q. Forward-looking statements contained in this announcement are made as of this date, and we undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

CONTACT: Leiv Lea of Pharmacyclics, Inc., +1-408-774-0330; or CarolynBumgardner Wang of WeissComm Partners, Inc., +1-415-225-5050, forPharmacyclics, Inc.

Web site: http://www.pharmacyclics.com/

Ticker Symbol: (NASDAQ-NMS:PCYC)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung Cancer
2. Pharmacyclics Announces Presentations and Published Abstracts on Xcytrin at The 2007 American Society of Clinical Oncology Annual Meeting
3. Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Brutons Tyrosine Kinase Inhibitors
4. Pharmacyclics Announces Presentations on Its Novel and Selective HDAC and Brutons Tyrosine Kinase Inhibitor Compounds
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:4/17/2015)... The issue: In consultation with ... (lot 710535) of Clavulin-400 (70mL) after receiving a complaint from ... one bottle of the  product. No other lots of GSK ... is an oral antibiotic used in adults and children aged ... comes as a powder in bottles and is mixed with ...
(Date:4/17/2015)... , April 17, 2015  Regulatory leaders in ... released bipartisan discussion draft called "21 st Century ... planned to be taken up by Congress soon and ... and medical device products are developed and marketed in ... reason, many companies have begun to consider how the ...
(Date:4/17/2015)... Ill. , April 17, 2015  AbbVie Inc. ("AbbVie") ... announced that it has extended the expiration of its exchange ... stock of Pharmacyclics, Inc. to 5 p.m., New ... On April 17, 2015, AbbVie also voluntarily withdrew ... Improvements Act in order to provide the FTC with additional ...
Breaking Medicine Technology:Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle 221st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 4
(Date:4/18/2015)... 2015 The Residential Senior Care ... past five years. The industry, which provides residential and ... fully care for themselves, has boomed on account of ... care for seniors with memory impairment. As a result, ... rate of 4.1% to $1.9 billion over the five ...
(Date:4/18/2015)... 18, 2015 Carinsurancesavings.biz has released a ... are cheaper during Spring. , Spring can ... plan. Drivers should make sure they compare the newest ... Clients can learn more about Spring car insurance offers ... Auto insurance quotes are becoming more and more popular. ...
(Date:4/18/2015)... April 18, 2015 "I wanted ... to create a healthful juice that contained essential ... Rosedale, Md. "It increases my energy, improves skin ... , He developed Tapp's Juice to contain fruits, ... to prevent physical and mental fatigue. It features ...
(Date:4/18/2015)... 18, 2015 Lowcostcarinsuranceprice.com has released a ... have on auto insurance prices . , ... of vehicle theft may have to pay more for ... auto insurance policies can also offer protection against vehicle ... be compared online on a single website: http://lowcostcarinsuranceprice.com/ ...
(Date:4/18/2015)... York, New York (PRWEB) April 18, 2015 ... ) filed on behalf of individuals who were ... replacement system continue to move forward in the U.S. ... Order dated April 10th, the Court has amended an ... of unrelated cases. Among other things, the new amendment ...
Breaking Medicine News(10 mins):Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 3
... Quick Patient-Information Retrieval From Multiple Medical ... Dec. 14 AT&T Inc. (NYSE: ... Ltd. (JOHA) has,awarded AT&T a three-year contract ... to other network solutions. Continuing its relationship,as ...
... Lancet Oncology publication provides important insights on the ... Test in clinical practice -, AMSTERDAM, The ... MammaPrint(R) breast cancer prognosis test was,successfully implemented in ... hospitals in The Netherlands. MammaPrint(R) assigned,up to one- ...
... in the last several decades, but at least one advance ... rise in women in prevalence, morbidity and mortality. By 2000, ... of men. But the rising number of cases in women ... apparent gender-bias. , The disease expression of COPD in women ...
... CHICAGO, Dec. 13 Advanced Life Sciences,Holdings, Inc. ... in the,discovery, development and commercialization of novel drugs ... today announced,that it completed its private placement of ... warrants to purchase approximately 5.1,million shares of common ...
... Hologic, Inc.,(Nasdaq: HOLX ) announced today ... recommended that the pre-market application for,Adiana(R) Permanent Contraception ... decision by a vote of 10 to 3., ... but traditionally follows the,recommendations of its advisory panels. ...
... a scandal now ensnaring,some of the nations leading ... Wal-Mart, Costco, Target, Safeway, and Wild Oats of ... legal filings in federal courts in Seattle, Denver, ... heels of class action,lawsuits against Aurora Dairy Corporation, ...
Cached Medicine News:Health News:Local Joliet Physician Group Selects AT&T for Managed Online Data Solutions 2Health News:Local Joliet Physician Group Selects AT&T for Managed Online Data Solutions 3Health News:Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen 2Health News:Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen 3Health News:When disease discriminates: Women and COPD 2Health News:When disease discriminates: Women and COPD 3Health News:Advanced Life Sciences Completes Private Placement for $20 Million 2Health News:Advanced Life Sciences Completes Private Placement for $20 Million 3Health News:FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable 2Health News:FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable 3Health News:FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable 4Health News:Nation's Largest Retailers Accused of Organic Fraud 2
Female High Waist Briefs...
Short-Sleeve Bolero for targeted compression in the upper arms, back and shoulder areas. Plush-shielded hook and eye front closure for comfort and convenient application....
Velcro® closure, uniform contour compression, available as 9" and 12" bands for abdominal support, 9" can be used as a breast wrap....
Bra With Cups...
Medicine Products: